viernes, 31 de octubre de 2025

EASO Algorithm: Matching Obesity Drugs to Complications +++++++ ++ +...

Trending in October Bisphosphonates for Aromatase Inhibitor Bone Loss https://www.medscape.com/viewarticle/consensus-bisphosphonates-aromatase-inhibitor-bone-loss-2025a1000rta?ecd=mkm_ret_251031_mscpmrk_endo_top-content_etid7839531&uac=148436CN&impID=7839531 GLP-1s and Libido: An Effect That May Fly Under the Radar https://www.medscape.com/s/viewarticle/glp-1s-and-libido-effect-may-fly-under-radar-2025a1000rbd?ecd=mkm_ret_251031_mscpmrk_endo_top-content_etid7839531&uac=148436CN&impID=7839531 New Sensor Doesn’t Require Needle to Measure Glucose https://www.medscape.com/viewarticle/biolinq-shine-new-sensor-doesnt-require-needle-measure-2025a1000sab?ecd=mkm_ret_251031_mscpmrk_endo_top-content_etid7839531&uac=148436CN&impID=7839531 Oral Semaglutide Reduces CV, MALE in T2D Regardless of PAD https://www.medscape.com/viewarticle/oral-semaglutide-reduces-major-adverse-cardiovascular-and-2025a1000q9a?ecd=mkm_ret_251031_mscpmrk_endo_top-content_etid7839531&uac=148436CN&impID=7839531 Artificial Intelligence’s Evolving Role in Diabetes Care https://www.medscape.com/viewarticle/artificial-intelligences-evolving-role-diabetes-care-2025a1000rik?ecd=mkm_ret_251031_mscpmrk_endo_top-content_etid7839531&uac=148436CN&impID=7839531 GERD Risk Higher With GLP-1s vs SGLT2s https://www.medscape.com/s/viewarticle/gerd-risk-higher-glp-1s-vs-sglt2s-2025a1000qmz?ecd=mkm_ret_251031_mscpmrk_endo_top-content_etid7839531&uac=148436CN&impID=7839531 Growth Hormone Benefits Kids With Rare Genetic Condition https://www.medscape.com/viewarticle/growth-hormone-benefits-kids-rare-genetic-condition-2025a1000m8e?ecd=mkm_ret_251031_mscpmrk_endo_top-content_etid7839531&uac=148436CN&impID=7839531 US Drug Spotlight Exenatide Injectable Solution https://reference.medscape.com/drug/byetta-exenatide-injectable-solution-342892?ecd=mkm_ret_251031_mscpmrk_endo_top-content_etid7839531&uac=148436CN&impID=7839531 Cabozantinib https://reference.medscape.com/drug/cometriq-cabometyx-cabozantinib-999791?ecd=mkm_ret_251031_mscpmrk_endo_top-content_etid7839531&uac=148436CN&impID=7839531 How does the new EASO algorithm align obesity complications with drug choices https://www.medscape.com/ai-search?query=How%20does%20the%20new%20EASO%20algorithm%20align%20obesity%20complications%20with%20drug%20choices&ecd=mkm_ret_251031_mscpmrk_endo_top-content_etid7839531&uac=148436CN&impID=7839531

No hay comentarios:

Publicar un comentario